Donald S. Fredrickson Conference


Submit Your Case | About Dr. Fredrickson | 2018 Conference Recap | 2018 Conference Agenda | 2018 Conference Faculty

The Donald S. Fredrickson Conference on Familial Lipoprotein Disorders provides a stimulating environment and stage for clinicians to share and discuss case reports of unusual disorders of lipoprotein metabolism. At the inaugural conference on April 29, 2018 in Las Vegas, six cases were presented, with each case followed by an expert-led discussion of the case. Attendees left with a better understanding of gene variants related to lipoprotein abnormalities, the advantages of genetic analysis and testing, and therapeutic targets and experimental techniques in development for genetic manipulation of inherited lipid disorders, with the ultimate goal of increasing the ability of clinicians to more effectively treat blood lipoprotein disorders. 

In addition to an annual on-site conference, there will be periodical webinars where chosen applicants will have the opportunity to present their case.

Submit your case at any time of the year to be considered!

W. Virgil Brown
W. Virgil Brown, MD, FNLA
Course Chair

Target Audience: Practicing clinicians, clinical researchers, basic scientists, and other healthcare professionals with an interest in lipid disorders.

Learning Objectives:

Upon completion of the conference, participants should be able to:

  • Discuss the value of genetic analysis and pertinent family history in unusual cases
  • Describe approaches to evaluating rare genetic disorders of lipoprotein metabolism
  • Discuss emerging therapeutic targets and experimental techniques in development for genetic manipulation of inherited lipid disorders
  • Apply insight from human population genetics studies to identify novel therapeutic targets for atherosclerotic cardiovascular disease
  • Analyze genetic information through case studies to improve treatment and prevention of cardiovascular disease

This conference is not certified for CME/CE credit.

Support for the inaugural 2018 conference was provided by Akcea Therapeutics and REGENXBIO.

No votes yet
Publish Date: 
Tuesday, February 20, 2018 - 13:00

Copyright © 2018 National Lipid Association. All Rights Reserved.

Privacy Policy Terms of Service